The long-term outcomes of sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGB) may differ in intention-to-treat (ITT) and per protocol (PP) populations.

The long-term outcomes of sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGB ... weight reduction or reflux (29.9 versus 5.5%). After 10 years, in the PP population, patients undergoing ...

Roux-en-Y gastric bypass led to greater weight loss than sleeve gastrectomy in patients with obesity at 10 years, according ...

Taking a GLP-1 receptor agonist prior to bariatric surgery may not boost long-term weight loss and metabolic benefits, a ...

MONDAY, Feb. 24, 2025 (HealthDay News) -- The long-term outcomes of sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGB) may differ in intention ... reduction or reflux (29.9 versus 5.5 percent ...

Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) Q4 2024 Earnings Call Transcript March 4, 2025 Amylyx Pharmaceuticals, Inc.

The center will offer laparoscopic sleeve gastrectomy, Roux-en-Y gastric bypass and endoscopic weight loss solutions ... program targeting individuals diagnosed with colorectal cancer before the age ...

placebo-controlled trial designed to evaluate efficacy and safety of avexitide in participants with PBH following Roux-en-Y gastric bypass (RYGB) surgery at approximately 20 sites in the U.S. Dosing ...